SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001554795-14-000046
Filing Date
2014-01-24
Accepted
2014-01-24 16:06:21
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-1 gnbt1212014forms1.htm S-1 5078719
2 EXHIBIT 5.1 gnbt1212014forms1ex5_1.htm EX-5.1 7698
3 EXHIBIT 23.1 gnbt1212014forms1ex23_1.htm EX-23.1 4206
4 GRAPHIC footer_231.jpg GRAPHIC 23051
5 GRAPHIC header231.jpg GRAPHIC 6190
  Complete submission text file 0001554795-14-000046.txt   17931256

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gnbt-20130731.xml EX-101.INS 2115342
7 XBRL SCHEMA FILE gnbt-20130731.xsd EX-101.SCH 184044
8 XBRL CALCULATION FILE gnbt-20130731_cal.xml EX-101.CAL 91265
9 XBRL DEFINITION FILE gnbt-20130731_def.xml EX-101.DEF 310258
10 XBRL LABEL FILE gnbt-20130731_lab.xml EX-101.LAB 1167131
11 XBRL PRESENTATION FILE gnbt-20130731_pre.xml EX-101.PRE 703343
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: S-1 | Act: 33 | File No.: 333-193548 | Film No.: 14546125
SIC: 2834 Pharmaceutical Preparations